Initial Study of Rituximab to Treat Primary Biliary Cirrhosis

Summary

The purpose of this study is to determine the safety of the anti-CD20 antibody rituximab in treating patients with Primary Biliary Cirrhosis (PBC). Rituximab is a laboratory-made antibody currently used to treat some kinds of lymphoma. Rituximab may also help people with PBC, a disease of the immune system. However, the safety of rituximab in PBC patients must first be established.

Timeline

Start

2007-01

Primary completion

2009-07

Completion

2009-12

Drugs

Indications